Zobrazeno 1 - 10
of 36
pro vyhledávání: '"L. Petriz"'
Autor:
A. Reig, C. Montagut, Mar Iglesias, Raquel Gallego, L. Petriz, D. Momblan, Miguel Pera, C. Balagué, Joaquim Bellmunt, M. Martin-Richard, Juan Maurel, Carlos Conill
Publikováno v:
ANNALS OF ONCOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Background: Based on a phase I study showing the feasibility of combining of oxaliplatin, cisplatin, and 5-fluorouracil (5-FU) (OCF) with radiation therapy (RT) in esophageal cancer, the efficacy of this regimen in esophageal, gastroesophageal (GE),
Autor:
Adriano Caixeta, Marco A. Costa, Fabio Sandoli de Brito, João L. Petriz, Carlos V. Serrano, Protásio Lemos da Luz
Publikováno v:
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac AngiographyInterventions. 69(4)
Objectives: The aims of this study were to investigate the effect of coronary stenting on the release of cytokines and cell-mediated immunity factors and to evaluate the association between inflammation and clinical outcomes at 6 months. Background:
Autor:
C. Garcia-Mora, Juan Ramón Ayuso, E. Sanchez-Santos, Jorge Aparicio, Juan Maurel, L. Petriz, M. Martin-Richard, Carles Conill, J. Feliu
Publikováno v:
Journal of Clinical Oncology. 29:e14525-e14525
e14525 Background: Sorafenib, an inhibitor of B-raf, VEGFR2, and PDGFR-beta, has activity against pancreatic cancer in pre-clinical models. Due to the radio-sensitization activity of S and G we des...
Autor:
Rosa Gallego, M. Martin-Richard, Carles Conill, Miguel Pera, C. Balaguer, Juan Maurel, L. Petriz, D. Momblan, C. Montagut, Mar Iglesias
Publikováno v:
Journal of Clinical Oncology. 27:e15612-e15612
e15612 Background: A phase I study showed the feasibility of the triplet combination (OPF) with XRT in ES and GE cancer (Maurel et al, IJRBOP, 2005). We conducted a phase II study to evaluate the efficacy of the regimen. Methods: Enrolled pts had res
Autor:
Laureano Fernández-Cruz, Maria Elena Sanchez, Rosa Gallego, Juan Maurel, Salvador Navarro, Rosana Cajal, Angels Ginès, Carles Conill, L. Petriz, M. Martin-Richard
Publikováno v:
Journal of Clinical Oncology. 24:4105-4105
4105 Background: Pancreatic cancers are resistant to radiotherapy (RT) and current chemotherapy agents. Epidermal growth factor receptor (EGFR) is over-expressed in pancreatic cancer and in vitro studies have shown that EGFR inhibitors can overcome r
Publikováno v:
Radiotherapy and Oncology. 60:S16
Publikováno v:
Radiotherapy and Oncology. 60:S5
Publikováno v:
Radiotherapy and Oncology. 47:S18
Autor:
C. Cinos, Albert Martínez, L. Petriz, J. Valencia, R. Galiana, Joaquı́n Gómez, S.O. Radioterapica
Publikováno v:
Radiotherapy and Oncology. 47:S26
Publikováno v:
Radiotherapy and Oncology. 40:S147